TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Human Leucocyte Antigen (HLA) specific Antibody detection and definition systems

Biomedical equipment
Diagnostic kits
Medical consumables
+2 more
UK
Published value
Not published
Submission deadline Not published
Lots published2
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Blood & Transplant: "Human Leucocyte Antigen (HLA) specific Antibody detection and definition systems". Published status: complete. Published value: Value not published. 2 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Blood & TransplantScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS Blood & Transplant
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Blood & Transplant. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2Bids / Report
42.9% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 14 active published awards; 14 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Blood & Transplant
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published4 Mar 2021, 22:56 GMT
Last source update4 Mar 2021, 22:56 GMT
Recurring procurementNot published
ClassificationBiomedical equipment, Diagnostic kits, Medical consumables, Medical equipments, Repair and maintenance services of medical equipment
Delivery area
UK
OCIDocds-h6vhtk-029880
What is being bought
Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor
What changed
From the official release history
  1. Status changed to complete
    4 Mar 2021, 22:56 GMT
  2. Official notice release published
    4 Mar 2021, 22:56 GMT
  3. Buyer information updated
    4 Mar 2021, 22:56 GMT
Lots and requirements (2)
Published by the contracting authority
  • Lot 1 · #1
    HLA Antibody Detection and Definition Systems
    cancelled
    Published valueNot published
    Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Maintenance of Existing Luminex Systems
    cancelled
    Published valueNot published
    Histocompatibility & Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: - Solid organ transplantation and clinical advice for donor selection - Haematopoietic stem cell transplantation and clinical advice for donor selection - Blood transfusion and transfusion reactions (SHOT) - Platelet refractoriness and provision of HLA/ HPA selected components - Platelet immunology - Granulocyte immunology - Immunogenetics including diagnostic testing and pharmacogenetics - Haematopoietic stem cell donor registry typing NHSBT require Human Leukocyte Antigen (HLA) antibody detection and definition systems. This is to ensure compatibility between donors and recipients of HLA selected platelets, haematopoietic stem cells for transplantation and solid organ transplantation (renal, liver and cardiothoracic). We must be able to perform HLA antibody detection and definition in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. For NHSBT these services are supplied through a national network of six laboratories located at Birmingham, Bristol, Colindale, Newcastle, Sheffield and Tooting. Scottish National Blood Transfusion Service (SNBTS) and Welsh Blood Service (WBS) are allowed to utilise this agreement. The Framework Agreement was awarded for 4 years and divided into lots as follows: Lot 1 - HLA Antibody Detection and Definition Systems - awarded to VH Bio Ltd and Immucor Lot 2 - Maintenance of Existing Luminex Systems - awarded to Immucor
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    4 Mar 2021, 22:56 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Contract active
    Signed 1 Mar 2021, 00:00 GMT · £123,000
  5. Contract active
    Signed 22 Feb 2021, 00:00 GMT · £7,020,000
Commercial outcome and competition
Awards
Immucor, VH Bio Ltd
Not published · Not published · active
Immucor
Not published · Not published · active
Contracts
Maintenance of Existing Luminex Systems
£123,000 · signed 1 Mar 2021, 00:00 GMT · active
HLA Antibody Detection and Definition Systems
£7,020,000 · signed 22 Feb 2021, 00:00 GMT · active
Bid statistics
bids: 3 (lot 1)
bids: 2 (lot 2)
Buyer and organisations in this procedure

NHS Blood & Transplant

Contracting authority GB-FTS-1395
View buyer profile

  • NHS Blood & Transplant
    buyer

    North Bristol Park, Filton, Bristol, UK, BS34 7QH
    marta.drozdzowska@nhsbt.nhs.uk

  • Immucor
    supplier

    Solihull, UK

  • NHS Blood and Transplant
    reviewBody

    Bristol

  • VH Bio Ltd
    supplier

    Gateshead, UK
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published